Otonomy Secures $49,000,000 Series D Funding Round

  • Feed Type
  • Date
    4/30/2014
  • Company Name
    Otonomy
  • Mailing Address
    6275 Nancy Ridge Drive San Diego, CA 92121 USA
  • Company Description
    Otonomy is a clinical stage biopharmaceutical company developing novel drug therapies for disorders of the inner and middle ear.
  • Website
    http://www.otonomy.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $49,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds from the financing will be used primarily to advance the company’s product pipeline through the potential filing for regulatory approval of OTO-201 in pediatric patients undergoing tympanostomy tube placement surgery, completion of the ongoing pivotal study of OTO-104 in Meniere’s disease patients, and advancement of OTO-311 into clinical development for the treatment of tinnitus.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy